Pathophysiology of Endovascular Resuscitation
Applied
Type
AdditionConfidence
72%
Created
Mar 27, 2026
Evidence
3 sources
Rationale
All three articles are reviews with moderate relevance scores (56–64) and were flagged rather than strongly recommended. However, each contributes a distinct and non-redundant point to this section: Latif 2023 reinforces the chain-of-survival framing of the opening paragraph; Stokes 2026 adds important military/combat context to the REBOA debate paragraph; and Fontenelle 2024 provides an updated complication profile directly relevant to the cREBOA bullet. Changes are targeted and minimal, matching the existing citation density and academic tone. No existing content was removed or contradicted.
Evidence
Content Changes
removedadded
<!-- type: physiology --> Hemorrhagic shock produces progressive **oxygen debt** and a self-reinforcing cycle of hypoperfusion, acidosis, hypothermia, and coagulopathy (“lethal("lethal triad/lethal diamond”).diamond"). Early hemorrhage control and **damage control resuscitation (DCR)** are therefore time-critical. [@rotondo1993] [@spahn2019] The "chain of survival" concept in traumatic hemorrhage emphasizes that each link — from point-of-injury hemorrhage control through definitive hemostasis — must be optimized to reduce preventable death [@latif2023-traumatic]. **Where endovascular trauma management (EVTM) fits in DCR** EVTM complements DCR by providing **rapid proximal or selective hemorrhage control** (e.g., resuscitative endovascular balloon occlusion of the aorta (REBOA), selective balloon occlusion, embolization, covered stents/stent-grafts) that can shorten time-to-hemostasis and reduce the duration of profound shock while definitive surgical/interventional radiology (IR) control is arranged. [@morrison2014] [@trauma2016-endovascular] However, the clinical benefit of REBOA remains a subject of intense debate; recent evidence from the UK-REBOA randomized clinical trial (RCT) indicated that the addition of REBOA to standard care in the emergency department (ED) did not improve survival and may even increase mortality, potentially due to procedural delays or complications [@jansen2026]. In the military/combat setting, REBOA has evolved from early experimental use toward more refined protocols, though its role in far-forward and austere environments continues to be refined as device technology and training pathways mature [@stokes2026-resuscitative]. **Physiologic principles of aortic balloon occlusion** - **Complete occlusion (cREBOA):** maximizes proximal perfusion but risks severe distal ischemia, reperfusion injury, and procedural complications such as vascular access site injury or arterial thrombosis; use the **shortest feasible occlusion time** and transition quickly to definitive control. [@bulger2019] [@marcelo2024] Reported complications include limb ischemia, access-site injury, aortic injury, and device-related failure, underscoring the importance of operator training and strict patient selection [@fontenelle2024-complications]. - **Partial/intermittent REBOA (pREBOA/iREBOA):** titrated deflation can preserve some distal flow and attenuate metabolic burden compared with continuous complete occlusion, especially as a bridge when definitive hemostasis is not yet achieved. [@sadeghi2018-partial] **Endovascular hemostasis and preservation of perfusion** Covered stents and stent-grafts can **exclude arterial disruption while maintaining in-line flow**, which is particularly valuable for junctional vessels (subclavian/axillary/iliac) that are difficult to expose surgically in unstable patients. [@markov2011] Embolization provides distal/branch control (e.g., pelvic arterial bleeding, solid organ injury) and is commonly integrated into pelvic hemorrhage pathways alongside packing and/or REBOA depending on physiology and resource availability. [@coccolini2017-wses] For surgical damage control concepts (packing, abbreviated laparotomy, open abdomen strategy), see [[Damage Control Surgery]] and [[Open Abdomen]]. [@wses2018]